Search Results
Results found for "Brian K Shoichet"
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
article Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling Sonja Peter , Brian
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Jang W, Senarath K, Feinberg G, Lu S, Lambert NA.
- 📰 GPCR Weekly News, January 29 to February 4, 2024
Sudha K Shenoy et al. perspectives of GPCR-based genetically encoded fluorescent indicators for neuromodulators Illuminating the brain-genetically
- Regulators of G-protein signaling: essential players in GPCR signaling
members of the RGS family are selective for certain GPCRs, as a proof RGS4 which is expressed in the brain Avrampou, K., et al., RGS4 Maintains Chronic Pain Symptoms in Rodent Models.
- Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage...
through G-protein-coupled receptors (GPCRs), fine-tune motoneuron (MN) IME by modulating background K+
- 📰 GPCR Weekly News, October 16 to 22, 2023
Brian Arey, and Dr. J. Silvio Gutkind.
- Decoding β-Arrestins: from Structure to function
hydrogen-deuterium exchange (HDX) mass spectrometry for time-dependent conformational insights (Komolov, K. proteins, presenting an array of effectors that could be recruited to GPCR–β-arrestin complexes (Xiao, K
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003).
- 📰 GPCR Weekly News, August 28 to September 3, 2023
Cell death signaling in Anopheles gambiae initiated by Bacillus thuringiensis Cry4B toxin involves Na+/K+
- 📰 GPCR Weekly News, December 18 to 31, 2023
Franziska M Heydenreich, Michel Bouvier, Brian Kobilka, M Madan Babu, and their team's work on Molecular
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
K., Hoppe, N., Huang, X.-P., Macdonald, C. B., Mehrotra, E., Patrick Rockefeller Grimes, Zahm, A.
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
BERKY consists of a membrane linker, a BRET donor, an ER/K α-helix linker, a BRET acceptor, and an active
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
full control of signaling activity through a small protein GPCR via library-based screening Dorgham, K. candidate hits from library-based screening so that they can be tested in cell-based assays Akondi, K. small proteins show full in vivo efficacy in a highly stringent model of HIV transmission Steinbach, K.
- Adhesion GPCR Consortium Newsletter - May 2024
Bandekar with help from Nathan Zaidman and Abhishek K. Singh
- Serotonin Receptor 5-HT2A Regulates TrkB Receptor Function in Heteroreceptor Complexes
accordance with our findings demonstrating the prevalence of 5-HT2A–TrkB heteroreceptor complexes in these brain especially the striatum, demonstrating that the balance between TrkB and 5-HT2A may shift in certain brain heterodimerization and suggest that the regulated expression of 5-HT2A and TrkB is a molecular mechanism for the brain-region-specific
- Glyco-sulfo hotspots in the chemokine receptor system
a single sialic acid, although, in rare cases glycans can carry polysialylation (PolySia) (Mindler K
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
The blood-brain-barrier (BBB) and the complexity of the central nervous system (CNS) pose a challenge GPCR Structure, Activation, and Signaling Pathways in the Brain An understanding of GPCR structure is Greater specificity : allows for selective tracking of receptor subtypes in complex brain tissues.
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
parallel pathways independently relay innate threat signals from different sensory modalities to multiple brain innate threat cues are integrated and conveyed from each sensory modality to the amygdala, a critical brain
- Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
September 2022 "Glutamate is the primary excitatory neurotransmitter in the brain and plays critical orthosteric and allosteric ligands acting on either mGluR2, mGluR3 or both for the management of these brain
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
September 2022 Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain electrophysiological studies, indicate that CB2 receptors are expressed in specific dopaminergic and glutamatergic brain
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
discovery programs in key therapeutic areas Kallyope, pioneers in drug discovery involving the gut-brain biopharmaceutical company, and New York City-based Kallyope, pioneers in drug discovery involving the gut-brain
- G-protein-coupled receptors as therapeutic targets for glioblastoma
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumour in adults. Despite this, the prognosis remains poor, with an impacted quality of life during treatment coupled with brain
- Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas ...
functions distinct from odor perception, and may contribute to the pathogenesis of disorders including brain Glioma is the most common adult malignant brain tumor and requires novel therapeutic strategies to improve Here, we outlined the expression of brain ORs and investigated OR expression levels in glioma.
- Diversity and specificity in location-based signaling outputs of neuronal GPCRs
by which members of the G protein-coupled receptor (GPCR) family respond to neurotransmitters in the brain
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
Exclusive access to private groups Over 30 recorded talks from Symposia - that's a lot of brain food To Design Novel GPCR- Targeted Antibody Therapeutics Using Generative AI Zombie Fungi Hijack Hosts’ Brains punctata GPCRs in Neuroscience Neuron specific quantitation of Gαolf expression and signaling in murine brain
- Illuminating the draggable GPCR-ome
Bryan Roth There are 10 open tickets available. Get yours now!
- In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and ...
Alterations in the expression and/or activity of brain G-protein-coupled receptors (GPCRs) such as dopamine Since studies have indicated that flavonoids can target brain GPCRs and provide neuroprotection via inhibition
- Chemogenetic stimulation of the G i pathway in astrocytes suppresses neuroinflammation
functional role of the astrocytic Gi pathway is not clear, as the literature is conflicting depending on the brain between enhanced calcium transients and the inflammatory phenotype of astrocytes observed in the inflamed brain
- Neurotransmitters: Potential Targets in Glioblastoma
September 2022 "For decades, glioblastoma multiforme (GBM), a type of the most lethal brain tumor, has
- AELIS PHARMA launches their IPO for €25 million
fundraising gives us the means to achieve our ambitions: to become a leading player in the field of brain








